Seroprevalence of Toxoplasma gondii among HIV Patients in Jahrom, Southern Iran.
- Author:
Hassan REZANEZHAD
1
;
Fateme SAYADI
;
Enayatollah SHADMAND
;
Seyed Dawood Mousavi NASAB
;
Hadi Rezaei YAZDI
;
Kavous SOLHJOO
;
Akbar KAZEMI
;
Monireh MALEKI
;
Abbas Ahmadi VASMEHJANI
Author Information
- Publication Type:Brief Communication
- Keywords: Toxoplasma gondii; HIV patient; seroprevalence; PCR; IgG; Jahrom; Iran
- MeSH: Antibodies; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Enzyme-Linked Immunosorbent Assay; HIV*; Humans; Immunocompromised Host; Immunoglobulin G; Iran*; Mortality; Polymerase Chain Reaction; Prevalence; Risk Factors; Seroepidemiologic Studies*; Toxoplasma*; Toxoplasmosis
- From:The Korean Journal of Parasitology 2017;55(1):99-103
- CountryRepublic of Korea
- Language:English
- Abstract: Toxoplasma gondii is an important opportunistic agent especially in immunocompromised hosts and can cause significant morbidity and mortality. Hence, detection and monitoring of anti-Toxoplasma antibodies are of a great interest in HIV-infected patients. A study on the prevalence of toxoplasmosis and associated risk factors was carried out among HIV-infected patients in Jahrom, southern Iran. The prevalence of anti-Toxoplasma IgG antibodies was 21.1% in HIV-infected patients by ELISA. PCR was performed on all of the samples, and 1 of the blood samples was positively detected. Among the HIV patients, anti-Toxoplasma IgG antibodies were significantly higher in age group of 30–39 years old (P=0.05). The seroprevalence of toxoplasmosis in patients with CD4+<100 cells/μl was 33.3% that was significantly higher than the other groups (P=0.042) with or without IgG antibodies. The CD4+ count mean of seropositive patients was lower than that of seronegative patients. The seroprevalence of toxoplasmosis in patients with highly active antiretroviral therapy was significantly less than patients without therapy (P=0.02). In conclusion, this study showed low seroprevalence of latent toxoplasmosis among HIV-infected patients in the region and confirmed the need for intensifying prevention efforts among this high-risk population and also the risk of toxoplasmosis reactivation which could be important among this population.
